Implementing the supply of emtricitabine 200mg/tenofovir alafenamide fumarate 25mg (TAF-FTC) as Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection Patient Group Direction (PGD)

March 2, 2026 Director - Public Health (Other) Approved View on council website